• Home
  • Trials in the GANNET53 EU Project
    • EUDARIO Clinical Trial
  • About Ovarian Cancer
    • Allgemeine Informationen
    • Diagnose
    • Therapie
    • Follow-up Care
    • Recurrence
  • About Clinical Trials
    • Types of Clinical Trials
    • The 4 Phases of a Clinical Trial
    • Importance of Clinical Trials
    • Importance of Translational Research
    • Datenschutz
  • Our Trials in the GANNET53 EU Project
    • EUDARIO Studie
    • GANNET53 Studie
      • Project Description
      • Trial Design
      • Planned Analysis
      • Patient Information
      • Results
  • Patients’ Advocacy
    • Ovarian and Uterine Cancer Support…
    • Gynaecological Cancer Support Group,…
    • Ovarcome Support Group, Vienna
    • Stiftung Eierstockkrebs
  • What Else Can I Do?
    • Diet and Cancer
    • Exercise
  • FAQ
    • What are the requirements for…
    • Why should I participate in this trial?
    • What are the rights and duties of trial…
    • Who supervises the conduct of a trial?
    • Will I be paid for participating in this…
    • Will I personally have to pay for…
    • Are there any risks if I participate in…
    • What if something happens to me during…
    • What is randomisation?
  • Bleiben Sie in Verbindung
    • Project Lead and Management
    • GANNET53 Trial Sites Near You

Patient Information

Below you can see a schematic diagram of an exemplary course of treatment during the GANNET53 trial. Please note that the actual course of treatment can differ from this schematic representation due to individual changes.

‘Please click on the images to enlarge’

Phase I

Phase_I_EN

Phase II

Phase_II_EN

Home | Contact | Legal Information | EN | DE | FR | NL
Copyright © 2023. All Rights Reserved.